News & Updates
Filter by Specialty:
Fremanezumab eases migraine and depressive symptoms
Treatment with fremanezumab – an anticalcitonin gene-related peptide (CGRP) – reduces depressive symptoms in patients with migraine and comorbid major depressive disorder (MDD) in the UNITE trial.
Fremanezumab eases migraine and depressive symptoms
13 Jul 2023
S-ketamine anaesthesia improves recovery following modified radical mastectomy
A prospective randomized controlled trial of breast cancer (BC) patients undergoing modified radical mastectomy (MRM) finds that S-ketamine used in place of sufentanil for general anaesthesia (GA) improves postoperative recovery.
S-ketamine anaesthesia improves recovery following modified radical mastectomy
12 Jul 2023
Newly diagnosed glaucoma ups risk of dementia
The risk of developing dementia, particularly Alzheimer’s disease (AD), is much higher among individuals with newly diagnosed glaucoma, suggests a study. Additionally, this association is much greater among older individuals.
Newly diagnosed glaucoma ups risk of dementia
03 Jul 2023
Barriers to physical activity limit stroke survivors in Singapore
Many stroke survivors in Singapore are willing to engage in physical activities (PAs), but they are usually encumbered by organizational, intrapersonal, and community barriers, reports a study.
Barriers to physical activity limit stroke survivors in Singapore
03 Jul 2023
Early menopause, premature ovarian insufficiency spell increased dementia risk
Early menopause or premature ovarian insufficiency may put women at increased risk of dementia, as reported in a recent study.